Billions in anti-aging, but science can't keep up with risks

The biotech industry invests billions of dollars in anti-aging therapies before science fully understands the mechanisms of aging. Researchers warn that manipulating biological processes responsible for age may carry unpredictable side effects. The longevity boom outpaces scientific evidence, raising serious questions about safety and ethics of such interventions.